Beijing 2016 - Programme

Our conference format is unique. The programme is interactive with a wide range of presentation formats, including plenary and breakout sessions. The content is relevant, innovative and enriching, and you will get the latest updates within the industry. Evening networking event provides an informal occasion to connect with fellow attendees. There will be simultaneous translation at the conference (EN>CN, CN>EN). 

The programme can be downloaded as pdf file here.

Programme

Expand all

 

07:30-08:30

Registration and welcome coffee

08:00-08:30

A starter session on GS1 standards

Introduction to global standards for Identify, Capture and Share

Mr. Jackie Du, Assistant Director, Promotion Dept., GS1 China

08:45-12:35

Opening Plenary Session: Pharmaceuticals/Traceability from manufacturer to patient

Traceability is an ubiquitous requirement in Healthcare – to improve patient safety through visibility in many business processes

08:45-09:00

Opening remarks and welcome to the conference

Ms. Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office
Mr. Miguel Lopera, President and CEO, GS1 Global Office

09:00-09:05

Welcome from GS1 China

Mr. Zhang Chengai, President and CEO, GS1 China

09:05-09:15

Official welcome

Senior Officer, Standardisation Administration of the People's Republic of China (SAC)

09:15-09:40

USA DSCSA requirements and implementation plans

Ms. Connie Jung, Senior Advisor for Policy, U.S. Food and Drug Administration (confirmed)

09:40-10:05

Pharmaceutical traceability in China

Ms. Gu Lihong, Senior Consultant, The Partnership For Safe Medicines (PSM) China (confirmed)

10:05-10:30

Traceacility from global manufacturer's perspective

Mr. Mike Dethick, Managing Director, The R&D-based Pharmaceutical Association Committee (RDPAC), China (confirmed)  

10:30-11:00

Coffee break 

11:00-11:25

EU Falsified Medicine Directive

Mr. Jerome Lepeintre, Minister Counsellor for Health and Food Safety, Delegation of the European Union to China and Mongolia (confirmed)

11:25-11:50

Evolution of traceability in Argentina

Dr. Maximiliano Derecho, Legal Advisor, National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina (confirmed)

11:50-12:15

Korea pharmaceuticals serialisation policy & national traceability system 

Ms. Kyoungja Lee, General Director, Pharmaceutical information management division of KPIS, Health Insurance Review and Assessment Service, Korea (confirmed)

12:15-12:20

Introduction to charity

Mr. Liu Dong, President, Beijing Chunmiao Children’s Aid Foundation, Director, Division of Cardiac Surgery, Beijing United Family Hospital and Clinics (BJU)

GS1 Healthcare supports a local charity with 5 EUR for every received feedback form.

12:20-12:25

Introduction to afternoon session

12:25-12:35

Introduction to presentations for the poster session

12:35-14:00

Networking lunch

14:10-15:40

Implementation Reality Sessions – Round 1 (register for one of the three)

Three concurrent breakout sessions on traceability or public policy (medical devices). Participants can choose from three sessions - session 1 and 2 will be repeated.

  • 1. Pharmaceutical traceability – what does it mean for the manufacturers and wholesalers 


    A mix of manufacturers and wholesalers will each present their respective approach to traceability, leveraging a combination of GS1 standards and product serialization. A panel discussion will round out the session, including a regulator’s perspective.

    Panellists: Ms. Peggy Staver, Director, Product Integrity, Pfizer; Mr. Jeffrey Denton, Senior Director, Secure Supply Chain, AmerisourceBergen Corporation; Mr. Michael Rose, Vice President, Supply Chain Visibility, Johnson & Johnson Supply Chain; Mr. Scott Mooney, Vice President Distribution Operations, McKesson; Dr. Maximiliano Derecho, Legal Advisor, ANMAT, Argentina
    Moderator: Mr. Craig Alan Repec, Senior Manager, Supply Chain Visibility, EPCIS & RFID, GS1 Global Office
     
  • 2. Traceability– implementation and benefits for hospitals and retail pharmacies


    Providers who have implemented GS1 standards for traceability in the care giving environment will share their experiences and advice: where to start, why, drivers, sponsorship and funding, the positive results and challenges

    Chair: Mr. Jean-Michel Descoutures, Chief of Pharmacy, Centre Hospitalier Victor Dupouy
    Panellists: Mr. Feargal Mc Groarty, National Haemophilia System Project Manager, St. James's Hospital, Ireland; Mr. Justin Bitter, Business Manager, Bernhoven Hospital, Netherlands; Mr. Peter Helmbaek, Senior Consultant, Amgros I/S, Denmark
     
  • 3. Public Policy: Medical Devices


    Regulatory requirements and initiatives from around the world related to medical devices - normally a closed group; it is only open for this session.

    Moderators: Ms. Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office; Ms. Jackie Rae Elkin, Global Process Owner, Standard Product Identification, Global Regulatory Affairs, Medtronic, Inc.

15:40-16:00

Coffee break 

16:00-17:30

Implementation Reality Sessions – Round 2 (repeat of 1 and 2, register for one of the two)

  • 1. Traceability – implementation and benefits for hospitals and retail pharmacie


    Chair: Mr. Jean-Michel Descoutures, Chief of Pharmacy, Centre Hospitalier Victor Dupouy

    Panellists: Mr. Feargal Mc Groarty, National Haemophilia System Project Manager, St. James's Hospital, Ireland; Mr. Justin Bitter, Business Manager, Bernhoven Hospital, Netherlands; Mr. Peter Helmbaek, Senior Consultant, Amgros I/S
  • 2. Pharmaceutical traceability – what does it mean for the manufacturers and wholesalers


    Panellists: Ms. Peggy Staver, Director, Product Integrity, Pfizer; Mr. Jeffrey Denton, Senior Director, Secure Supply Chain, AmerisourceBergen Corporation; Mr. Michael Rose, Vice President, Supply Chain Visibility, Johnson & Johnson Supply Chain; Mr. Scott Mooney, Vice President Distribution Operations, McKesson; Dr. Maximiliano Derecho, Legal Advisor, ANMAT, Argentina
    Moderator: Mr. Craig Alan Repec, Senior Manager, Supply Chain Visibility, EPCIS & RFID, GS1 Global Office

17:30-18:30

Poster reception

Discover the latest GS1 Healthcare implementations and initiatives developed by GS1 Member Organisations – vote for the best poster

17:30-19:00

International Government Healthcare Supply Chain Think Tank
(Invitation only)

Open to international government healthcare organisations – discussions will be held under the Chatham House Rule

08:30-09:00

Welcome coffee

09:00-13:00

Plenary session – Unique Device Identification (UDI) and regulatory Track & Trace initiatives for Medical Devices

UDI aims to establish a single device identification system that is consistent, unambiguous and globally standardised. The session provides an overview of the status on UDI across the world and informs on other initiatives regarding track & trace for medical devices.

09:00-09:25

Latest advances CFDA made on regulations for UDI

Ms. Li Jun, Division Director of the Department of Medical Device Registration, CFDA

09:25-09:50

The new MD regulation in Europe

Mr. Salvatore Scalzo, Policy and Legal Officer, DG for Internal Market, Industry, Entrepreneurship and SMEs, Health Technology and Cosmetics, European Commission (confirmed)

09:50-10:15

Medical Device Track and Trace System in Turkey Cooperated by Turkish Medicines and Medical Devices Agency and The Scientific and Technological Research Council of Turkey

Mr. Ömer Özkan, Institute deputy manager, TÜBITAK BILGEM Software Technologies Research Institute (confirmed)

10:15-10:40

UDI regulation & implementation in the U.S.

Mr. Jay Crowley, Vice President and UDI Practice Lead, USDM Life Sciences (confirmed)

10:40-11:10

Regulation on traceability of medical devices in Argentina

Dr. Maximiliano Derecho, Legal Advisor, ANMAT, Argentina (confirmed)

11:10-11:40

Coffee break

11:40-12:05

UDI implementation from manufacturer's view

Ms. Eva Chow, IT Director, Medtronic (confirmed)

12:05-12:30

UDI Implementation in Shanghai Shuguang Hospital

Mr. Zhou Hua, President, Shanghai Shuguang Hospital, China (confirmed)

12:30-12:55

Global standards for an international company

Ms. Kathryn E. Wengel, Worldwide Vice-President & Chief Supply Chain Officer, Management committee member, Johnson & Johnson (confirmed)

12:55-13:00

Introduction to afternoon sessions

13:00-14:00

Networking lunch

14:00-15:30

Implementation reality sessions - round 1 (register for one of the three).

Three concurrent breakout sessions on how to implement UDI or public policy (Pharmaceuticals and vaccines). Participants can choose from three sessions - session 1 and 2 will be repeated:

  • 1. Implementation sessions on UDI - marking/labelling


    Need a better understanding of the steps involved in the implementation of the Automatic Identification and Data Capture (AIDC) based identification and marking of medical devices for the U.S. FDA UDI rule as well as other global UDI initiatives? Join this session to learn about the challenges and successes from our panellists as they share their practical experiences and answer your UDI AIDC implementation questions.

    Panellists: Mr. Chuck Biss, Senior Director, AIDC Healthcare, GS1 Global Office; Ms. Jackie Rae Elkin, Global Process Owner, Standard Product Identification, Global Regulatory Affairs, Medtronic, Inc; Mr. Tom Werthwine, Director, Industry Standards, Supply Chain Visibility, Johnson & Johnson; Mr. Stan Malinowski, Mgr Mfg Sys Integration, UDI Lead GS1 Standards & Marking Technologies, Strategic Project Management, Medtronic

     
  • 2. Implementation sessions on UDI - Data/GDSN 


    Master Data Management is one of the most challenging areas relating to the implementation of the UDI regulation and Global Data Synchronisation. It involves the management of information at global and local levels. Inconsistent, incomplete and incorrect data increase the risk of patient safety errors and the cost of healthcare across the entire supply chain. The ultimate value of data quality translates to patient safety and improved lives for the caregivers. Join this session as panellists share their experiences in getting ready to provide data to the FDA’s GUDID and the lessons learned from their GDSN implementation success stories.

    Panellists: Mr. Nick Manzo, Global Omni-Channel Commercial Lead, 1WorldSync; Ms. Catherine Koetz, Industry Manager - Healthcare, GS1 Australia; Fengming Mao, Assistant Director, GDSN, IT Dept., GS1 China; Mr. Peter Alvarez, Sr. Director Master Data Management, GS1 Global Office

     
  • 3. Public policy: Pharmaceuticals and vaccines


    Regulatory requirements and initiatives from around the world related to pharmaceuticals and vaccines - normally a closed group; it is only open for this session.

    Moderators: Ms. Géraldine Lissalde-Bonnet, Public Policy Director, GS1 Global Office; Ms. Peggy Staver, Director, Product Integrity, Pfizer, Co-Chair Public Policy work group
 
15:30-16:00

Coffee break

16:00-17:30

Implementation reality sessions - round 2 (repeat of 1 and 2, register for one of the two)

  • 1. Implementation sessions on UDI - Data/GDSN


    Panellists: Mr. Nick Manzo, Global Omni-Channel Lead, 1WorldSync; Ms. Catherine Koetz, Industry Manager - Healthcare, GS1 Australia; Fengming Mao, Assistant Director, GDSN, IT Dept., GS1 China; Mr. Peter Alvarez, Sr. Director Master Data Management, GS1 Global Office

     

  • 2. Implementation sessions on UDI - marking/labelling


    Panellists: Mr. Chuck Biss, Senior Director, AIDC Healthcare, GS1 Global Office; Ms. Jackie Rae Elkin, Global Process Owner, Standard Product Identification, Global Regulatory Affairs, Medtronic, Inc; Mr. Tom Werthwine, Director, Industry Standards, Supply Chain Visibility, Johnson & Johnson; Mr. Stan Malinowski, Mgr Mfg Sys Integration, UDI Lead GS1 Standards & Marking Technologies, Strategic Project Management, Medtronic
19:00-22:30

Networking event

The networking event will take place at the Grand Mansion Asian Games Village Restaurant
08:30-09:00

Welcome coffee

09:00-11:05

Plenary session – Hospital implementation

In this session providers who have implemented GS1 standards in the care giving environment will share their experiences and advice

09:00-09:25

Global standards - the foundation for developing hospital information system

Mr. Wang Jian, Director of medical affair of medical support department, The General Hospital of the People's Liberation Army (confirmed)

09:25-9:50

Implementation of standardised traceability system in Japan

Dr. Chikayuki Ochiai, M.D., D.M.Sc., Professor of Tokyo Healthcare University, Honorary CEO of NTT Medical Center, Tokyo (confirmed)

9:50-10:15

National Drug Information Sharing in the Thailand Health Care Supply Chain

Assoc. Prof. Dr. Duangpun Kritchanchai, Healthcare Supply Chain Excellence Centre, Centre of Logistics Management, Faculty of Engineering, Mahidol University, Thailand (confirmed)

10:15-10:40

GS1 implementation in Shanghai East Hospital

Mr. Xu Zhaohui, Vice President, Shanghai East Hospital, China

10:40-11:15

Coffee break

11:15-13:00

Plenary session - Hospital implementation - continued

11:15-11:25
  • HPAC Award


    The GS1 Healthcare Provider Advisory Council (HPAC) provides two awards for:
    1. an individual who has contributed extensively to furthering GS1 Healthcare's work efforts over the years;
    2. a provider organisation that has implemented GS1 standards for at least one process in their organisation 
11:25-11:50

Presentation of winner of the 'Provider Recognition Award'

11:50-12:15

Presentation of winner of the 'Provider Implementation Best Case Study Award'

12:15-12:40

The New Era of Healthcare

Mr. Ashley Brooks, NHS Patient Champion, UK (confirmed)

12:40-12:50

Invitation to the next conference in Berlin, Germany

Mr. Juergen Schmitz, Head of Sales, GS1 Germany

12:50-13:10

Closing remarks – GS1 Healthcare Tri-Chairs

 

Afternoon

Travel to Shanghai (optional, by registration only)

Site visits at Shanghai Shuguang Hospital or Shanghai East Hospital on Friday 28 October.

08:30

Departures from Grand Kempinski Hotel Shanghai

9:00-11:30

Introduction

Management system in operating theatre

Management system in hospital pharmacy

11:30-12:00

Back to hotel

12:00 

Lunch

 

Expand all

Which of the following best describes the primary purpose of your visit?

Success

Thank you for your feedback!

Were you able to find the information you were looking for on our website?

Success

Thank you for your feedback!